Predictors of Warfarin Use Among Ohio Medicaid Patients With New-Onset Nonvalvular Atrial Fibrillation

Johnston, Joseph A.; Cluxton, Robert J.; Heaton, Pamela C.; Guo, Jeff J.; Moomaw, Charles J.; Eckman, Mark H.

doi:10.1001/archinte.163.14.1705

Cited by 68 publications

(58 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Data on the association between cardiovascular diseases as congestive heart failure and ischemic heart disease with Coumadin compliance was demonstrated in various studies and supports these findings. It is assumed that having increased risk of stroke due to other cardiovascular morbidities increases both patient and care-giver focus on stroke prevention with anti-coagulation treatment (Johnston et al, 2003). Although we did not observe significant differences between compliant and noncompliant patients regarding hospitalisation days, in Phase 2 of the study non-compliant patients were hospitalised almost twice as long (at average) as were compliant patients, and they used the health care services approximately twice as much as compliant patients.…”

Section: Discussioncontrasting

confidence: 63%

See 1 more Smart Citation

Risk Factors Affect Long-Term Compliance to Coumadin Treatment (Self-Reporting)

Tzivian

Folkmanis

Warshawsky-Livne

et al. 2017

Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.

View full text Add to dashboard Cite

Section: Discussioncontrasting

confidence: 63%

“…The reason for that difference might be because younger AF patients do not receive Coumadin as commonly as older patients. Older age (³85 years), as well as younger age (<55 years) decrease the use of warfarin (Johnston et al, 2003). Therefore, the association between age and Coumadin is nonlinear.…”

Section: Discussionmentioning

confidence: 99%

Risk Factors Affect Long-Term Compliance to Coumadin Treatment (Self-Reporting)

Tzivian

Folkmanis

Warshawsky-Livne

et al. 2017

Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.

View full text Add to dashboard Cite

“…A recent retrospective study of cardiac arrest in anesthesia used the same institutional databases [25]. For quality-assurance and regulatory purposes, institutional databases are necessary, and studies using institutional databases have now come of age [26,27].…”

Section: Study Limitationsmentioning

confidence: 99%

Morbidity and mortality of deep sedation in outpatient bone marrow biopsy

et al. 2004

View full text Add to dashboard Cite

Deep sedation is being provided at an increasing rate for patients undergoing bone marrow biopsy and aspiration (BMBA). The aim of this study was to establish the safety of deep sedation used for adults undergoing BMBA. A nonrandomized database analysis and retrospective review of patient records from January 1997 to December 2000 was performed; 5,811 patients were identified as having undergone their first outpatient BMBA. Outcome measures included 30-day mortality and same-day hospital admission; surrogate measures included need for a surgical procedure or receipt of red blood cells within the 48 hr following the BMBA. Patients who received intravenously administered midazolam, fentanyl, and propofol for maintenance of deep sedation plus infiltration of a local anesthetic (n = 2,604; 45%) comprised the deep sedation group; those who received infiltration of a local anesthetic but no intravenous sedation or analgesia (n = 3,207; 55%) comprised the local anesthesia group. Patients in the deep sedation group compared to those in the local anesthesia group were less likely to die within 30 days (0.69% vs. 1.34%, P = 0.018) and less likely to receive red blood cells (1.27% vs. 2.25%, P = 0.006). No other differences between the groups were found. Although the study was retrospective and nonrandomized, the results suggest that the use of deep sedation for outpatient BMBA is as safe as using local anesthesia. Am.

show abstract

“…The available data derive from the experiences on patients using VKAs. Various studies have shown that adherence to therapy with VKAs were affected by ethnical origin, economic status, educational level, employment status, missing doses, lack of knowledge on drug usage, use of additional drugs, drug and alcohol dependence, and emotional factors [23][24][25][26]. IN-RANGE study investigated factors affecting adherence to therapy with VKAs for the duration of 32 months.…”

Section: Causes Of Non-adherencementioning

confidence: 99%

Evaluation of drug adherence in patients with non-valvular atrial fibrillation according to geographic regions of Turkey: an analysis from NOAC-TR study

Emren¹,

Zoghi²,

Açıksarı³

et al. 2017

Med-Science

View full text Add to dashboard Cite

Drug adherence to novel oral anticoagulants (NOAC) varied by countries and popuplations. As a result of NOAC-TR study, in Turkey, drug adhrence to NOACs is poor comparing to other real world studies. However it is not known whether there is a difference between geographic regions of Turkey in terms of NOAC adherence. In this study we aim to investigate the NOAC adherence in patients with non-valvular atrial fibrillation according to the geographic regions in Turkey Method: This cros-sectional study was designed as a subgroup study of NOAC-TR (Drug Adherence in patients with non valvular atrial fibrillation taking non-vitamin K antagonist oral anticoagulants in Turkey). A total of 2802 patients (59% female) taking NOAC (Dabigatran, apixaban, rivaroxaban) due to NVAF at least 3 months, were included. Morisky-8 item drug adherence scale was used. Patients were divided in 3 groups (high, moderate and low adherent) based on drug adherence Results: Of the patients 24% were adherent, 26% were moderate adhererent and 50% were low adherent to NOAC treatment. Drug adhrence was different between geographic regions (p<0,001). In post-hoc analysis low adherent rate was highest in Blacksea region (72% low adherent, 21% moderate adherent, 7% low adherent). Adherence rate was highest in Aegean (36% adherent, 26% moderate adherent 38%) and Marmara region (38% adherent, 28% moderate adherent 34% low adherent). Conclusion: NOAC adherence was different between geographic regions in Turkey.

show abstract

Predictors of Warfarin Use Among Ohio Medicaid Patients With New-Onset Nonvalvular Atrial Fibrillation

Cited by 68 publications

References 32 publications

Risk Factors Affect Long-Term Compliance to Coumadin Treatment (Self-Reporting)

Risk Factors Affect Long-Term Compliance to Coumadin Treatment (Self-Reporting)

Morbidity and mortality of deep sedation in outpatient bone marrow biopsy

Evaluation of drug adherence in patients with non-valvular atrial fibrillation according to geographic regions of Turkey: an analysis from NOAC-TR study

Contact Info

Product

Resources

About